The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens
The nasopharynx is the primary site of colonization by respiratory pathogen that constitutes the port of entrance in the respiratory tract. The role of mucosal respiratory microbiota in infection has been recently emphasized; therefore, we aimed to assess if a specific respiratory microbiota profile was associated with symptomatic infection and/or with presence of respiratory viruses. We performed a case-control study to characterize the healthy respiratory microbiota and its alteration during acute viral infections. Next-generation sequencing of the 16S rRNA gene was applied to 225 nasopharyngeal samples from 177 patients with viral respiratory infection and 48 matched healthy controls. We evidenced an important decrease of bacterial alpha-diversity in patients with symptomatic respiratory infection and a loss of the healthy core microbiota, specifically anaerobes and Prevotella spp. Moreover, eight respiratory pathogens were enriched in these patients, including Staphylococcus aureus, Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Dol osigranulum pigrum and Corynebacterium propinquum/pseudodiphtheriticum, whose role in respiratory infection is unclear. The asymptomatic carrier of influenza harbors a microbiota similar to healthy subjects, suggesting a critical role of microbiota in the clinical expression of viruses. These data suggest that the commensal microbiota plays a significant role in susceptibility to viral infection. The frequent co-detection of virus and bacteria raises the question of a strategy to prevent bacterial disease, focusing on the prevention of nasopharyngeal colonization through effective antibiotic treatment. In addition to antibiotics, further studies should test preventive or therapeutic interventions for maintaining or restoring a healthy nasopharyngeal microbiota.
KeywordsHuman Respiratory infection Microbiome Microbiota Virus Respiratory tract infection
This work was supported by the French Government under the “Investissements d’avenir” (Investments for the Future) program managed by the Agence Nationale de la Recherche (ANR, fr: National Agency for Research), (reference: Méditerranée Infection 10-IAHU-03).This work was also supported by Région Provence Alpes Côte d’Azur and European funding FEDER PRIMMI (Fonds Européen de Développement Régional - Plateformes de Recherche et d'Innovation Mutualisées Méditerranée Infection).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The study was approved by the local Ethics Committee (number 2016-016).
Written informed consent was obtained for all the controls included on a voluntary basis. For cases, metagenomics was performed on excess respiratory sample received in our laboratory for routine diagnosis of viral respiratory infections. Under the French law, patient consent was not required for this type of non-interventional study, provided the patients had received information and retained the right to oppose the use of excess respiratory samples and anonymized medical data (14–15).
- 1.Byington CL, Ampofo K, Stockmann C, Adler FR, Herbener A, Miller T, Sheng X, Blaschke AJ, Crisp R, Pavia AT (2015) Community surveillance of respiratory viruses among families in the Utah better identification of germs-longitudinal viral epidemiology (BIG-LoVE) study. Clin Infect Dis 61(8):1217–1224CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Skevaki CL, Tsialta P, Trochoutsou AI, Logotheti I, Makrinioti H, Taka S, Lebessi E, Paraskakis I, Papadopoulos NG, Tsolia MN (2015) Associations between viral and bacterial potential pathogens in the nasopharynx of children with and without respiratory symptoms. Pediatr Infect Dis J 34(12):1296–1301CrossRefPubMedGoogle Scholar
- 6.de Steenhuijsen Piters WA, Heinonen S, Hasrat R, Bunsow E, Smith B, Suarez-Arrabal MC, Chaussabel D, Cohen DM, Sanders EA, Ramilo O, Bogaert D, Mejias A (2016) Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am J Respir Crit Care Med 194(9):1104–1115CrossRefPubMedPubMedCentralGoogle Scholar
- 10.Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N, Holt BJ, Hales BJ, Walker ML, Hollams E, Bochkov YA, Grindle K, Johnston SL, Gern JE, Sly PD, Holt PG, Holt KE, Inouye M (2015) The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 17(5):704–715CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Korten I, Mika M, Klenja S, Mack I, Barbani MT, Gorgievski M, Frey U, Hilty M, Latzin P (2016) Interactions of respiratory viruses and the nasal microbiota during the first year of life in healthy infants. mSphere 1(6)Google Scholar
- 12.Langevin S, Pichon M, Smith E, Morrison J, Bent Z, Green R, Baker K, Solberg O, Gillet Y, Javouhey E, Lina B, Katze MG, Josset L (2017) Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study. J Gen Virol. Sep 8Google Scholar
- 19.Million M, Tidjani AM, Khelaifia S, Bachar D, Lagier JC, Dione N, Brah S, Hugon P, Lombard V, Armougom F, Fromonot J, Robert C, Michelle C, Diallo A, Fabre A, Guieu R, Sokhna C, Henrissat B, Parola P, Raoult D (2016) Increased gut redox and depletion of anaerobic and methanogenic prokaryotes in severe acute malnutrition. Sci Rep 6:26051CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Anderson MJ (2001) A new method for non parametric multivariate analysis of variance. Austral Ecology 26:32–46Google Scholar
- 23.Ederveen THA, Ferwerda G, Ahout IM, Vissers M, de Groot R, Boekhorst J, Timmerman HM, Huynen MA, van Hijum SAFT, de Jonge MI (2018) Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses. Microbiome 6(1):10CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Chonmaitree T, Jennings K, Golovko G, Khanipov K, Pimenova M, Patel JA, McCormick DP, Loeffelholz MJ, Fofanov Y (2017) Nasopharyngeal microbiota in infants and changes during viral upper respiratory tract infection and acute otitis media. PLoS One 12(7):e0180630CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Larsen JM, Steen-Jensen DB, Laursen JM, Søndergaard JN, Musavian HS, Butt TM, Brix S (2012) Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One 7(2):e31976CrossRefPubMedPubMedCentralGoogle Scholar
- 32.Bosch AA, Levin E, van Houten MA, Hasrat R, Kalkman G, Biesbroek G, de Steenhuijsen Piters WAA, de Groot PCM, Pernet P, Keijser BJF, Sanders EAM, Bogaert D (2016) Development of upper respiratory tract microbiota in infancy is affected by mode of delivery. EBioMedicineGoogle Scholar
- 35.Kanmani P, Clua P, Vizoso-Pinto MG, Rodriguez C, Alvarez S, Melnikov V, Takahashi H, Kitazawa H, Villena J (2017) Respiratory commensal bacteria Corynebacterium pseudodiphtheriticum improves resistance of infant mice to respiratory syncytial virus and Streptococcus pneumoniae superinfection. Front Microbiol 8:1613CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Salter SJ, Turner C, Watthanaworawit W, de Goffau MC, Wagner J, Parkhill J, Bentley SD, Goldblatt D, Nosten F, Turner P (2017) A longitudinal study of the infant nasopharyngeal microbiota: the effects of age, illness and antibiotic use in a cohort of South East Asian children. PLoS Negl Trop Dis 11(10):e0005975CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Prevaes SM, de Winter-de Groot KM, Janssens HM, de Steenhuijsen Piters WA, Tramper-Stranders GA, Wyllie AL, Hasrat R, Tiddens HA, van Westreenen M, van der Ent CK, Sanders EA, Bogaert D (2016) Development of the nasopharyngeal microbiota in infants with cystic fibrosis. Am J Respir Crit Care Med 193(5):504–515CrossRefPubMedGoogle Scholar